Drugs Information:
Riluzole
Basic Information
|
|
||
| ID | DDInter1596 | |
| Drug Type | small molecule | |
| Molecular Formula | C8H5F3N2OS | |
| Molecular Weight | 234.198 | |
| CAS Number | 1744-22-5 | |
| Description | A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi. | |
| ATC Classification | N07XX02 | |
| IUPAC Name | 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine | |
| InChI | FTALBRSUTCGOEG-UHFFFAOYSA-N | |
| Canonical SMILES | NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2 | |
| Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Guide to Pharmacology Wikipedia ChEMBL ZINC | |
Interactions with
Riluzole
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|